Indication

Sinusitis, Hay fever, Allergic and non-allergic rhinitis, Nasal Polyps (Postsurgical Prophylaxis), Vasomotor Rhinitis

Administration

Shake well before each use\r\nBefore first use, prime pump by 6 actuations into air\r\nIf not used for 7 days, reprime pump until fine spray appears

Adult Dose

Adults: The usual dosage is 1-2 inhalations in each nostril twice a day .\r\n\r\n

Child Dose

Children 12 Years of Age and Older: The usual dosage is 1-2 inhalations in each nostril twice a day .\r\n\r\nChildren 6 to 12 Years of Age: Patients should be started with 1 inhalation in each nostril twice a day; \r\npatients with more severe symptoms may use 2 inhalations in each nostril. \r\n\r\n<6 years: Safety and efficacy not established

Contraindication

patients with a history of hyper-sensitivity to any of the components

Mode of Action

Beclometasone controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes, fibroblasts, reverses capillary permeability and lysosomal stabilisation at the cellular level to prevent or control inflammation.

Precaution

Nasal passage infections and paranasal sinuses should be appropriately treated.\r\n\r\nCaution should be exercised whilst transferring patients from systemic steroid treatment to Beclometasone Dipropionate Aqueous Nasal Spray if there is doubt that their adrenal function is impaired.\r\n\r\nSystemic effects of nasal corticosteroids may occur particularly at high doses prescribed for prolonged periods. Growth retardation has been reported in children receiving nasal corticosteroids at licensed doses.\r\n\r\nTreatment with higher than recommended doses may result in clinically significant adrenal suppression. If there is evidence for higher than recommended doses being used then additional systemic corticosteroid cover should be considered during periods of stress or elective surgery.\r\n\r\nLactation: Unknown whether distributed in breast milk; use caution

Side Effect

>10%\r\nNasopharyngeal irritation (24%)\r\n\r\n1-10%\r\nHeadache (<5%),Nausea (<5%),Lightheadedness (<5%),Sneezing attacks after administration (4%),Nasal congestion (<3%),Nose bleeds (<3%),Rhinorrhea (<3%),Increased lacrimation (<3%),Epistaxis (<3%)\r\n\r\nFrequency Not Defined\r\nNasal mucosa ulceration,Nasal septum perforation

Pregnancy Category Note

Pregnancy Category: C\r\n\r\nLactation: Unknown whether distributed in breast milk; use caution